DiamPark is an R&D neurotech whose vocation is to characterize and achieve innovative solutions based on the capture, measurement and analysis of digital neuromarkers specific to Parkinson's disease. The offer is twofold, a patient support and monitoring program and a reliable digital evaluation tool for the progression of the disease and the therapeutic effects of drugs in real life and in R&D.